Anita Chakraverty

Many DNA variants linked with neuropsychiatric disorders (NPD) that do not code for proteins depend on neuronal activation, a study suggests.

Researchers have developed AI tool to rival the behemoth of Google's Alphafold 3 in predicting 3D shapes in RNA using less data.

Several genes relating to plasma proteins—particularly those involved in the immune system—have been linked for the first time with Alzheimer's disease.

Antidepression treatment based on a person's individual biomarkers could help determine which of the world's most popular medications to use, a clinical trial suggests.

A high-fat diet can result in better outcomes from cancer immunotherapy by improving the balance of microbes in the gut, early research shows.

A portable AI tool can estimate the age of an unborn baby from scans as well as trained sonographers, potentially extending access to vital prenatal ultrasonography where it might not otherwise be available.

The multi-skilled biomedical AI agent Biomni can speed the progress of biomedicine, automating tasks and accelerating the process from basic research to clinical application.

Next-generation electrode “tattoos” that can be painted onto skin could enable comfortable and reliable health monitoring to personalized designs.

A blood-based biomarker could predict a person's risk of developing Alzheimer's disease years before any symptoms arise, research suggests.

A study has revealed how white blood cells in the body react to the Epstein-Barr virus (EBV) in a way that drives autoimmunity in multiple sclerosis (MS), which could help identify and design effective therapies for the condition.